Trials / Completed
CompletedNCT03388333
Biomarkers in Patients Undergoing Atrial Fibrillation Ablation
A Single-center Observational Study to Find Biomarkers for the Outcome of Catheter Ablation in Patients With Atrial Fibrillation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The investigators aim to find biomarkers to determine the success of pulmonary vein isolation for the treatment of atrial fibrillation.
Detailed description
The investigators perform an observational study in patients undergoing pulmonary vein ablation to treat atrial fibrillation. Additionally, electrophysiological procedures not related to pulmonary vein isolation are also followed. The aim of the study is finding biomarkers that are able to predict short-term outcome of the procedure.The primary endpoint is defined as reoccurrences of atrial fibrillation within the first three months after pulmonary vein isolation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Catheter Ablation |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2018-07-01
- Completion
- 2019-04-01
- First posted
- 2018-01-02
- Last updated
- 2019-06-07
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03388333. Inclusion in this directory is not an endorsement.